Millennium Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.6K Sell
187,418
-3,396,870
-95% -$5.34M ﹤0.01% 5410
2025
Q4
$11.1M Sell
3,584,288
-35,041
-1% -$100K ﹤0.01% 2153
2025
Q3
$9.52M Buy
3,619,329
+3,123,081
+629% +$6.88M ﹤0.01% 2436
2025
Q2
$610K Sell
496,248
-2,181,788
-81% -$2.38M ﹤0.01% 4764
2025
Q1
$2.95M Sell
2,678,036
-908,031
-25% -$1.05M ﹤0.01% 3412
2024
Q4
$3.24M Buy
3,586,067
+457,179
+15% +$392K ﹤0.01% 3228
2024
Q3
$3.09M Sell
3,128,888
-2,468,490
-44% -$2.37M ﹤0.01% 3275
2024
Q2
$5.04M Sell
5,597,378
-898,042
-14% -$672K ﹤0.01% 2721
2024
Q1
$7.66M Buy
6,495,420
+2,270,810
+54% +$2.5M ﹤0.01% 2440
2023
Q4
$3.85M Sell
4,224,610
-2,826,750
-40% -$2.09M ﹤0.01% 3013
2023
Q3
$5.87M Buy
7,051,360
+2,844,283
+68% +$3.28M ﹤0.01% 2548
2023
Q2
$5.05M Sell
4,207,077
-1,253,303
-23% -$1.56M ﹤0.01% 2662
2023
Q1
$6.88M Buy
5,460,380
+834,869
+18% +$1.6M ﹤0.01% 2307
2022
Q4
$10M Buy
4,625,511
+3,296,396
+248% +$27.1M 0.01% 2113
2022
Q3
$15.9M Sell
1,329,115
-151,590
-10% -$1.88M 0.01% 1581
2022
Q2
$12.4M Buy
1,480,705
+1,307,018
+753% +$10.1M 0.01% 1775
2022
Q1
$1.51M Sell
173,687
-35,205
-17% -$340K ﹤0.01% 4121
2021
Q4
$2.36M Sell
208,892
-299,898
-59% -$3.56M ﹤0.01% 3617
2021
Q3
$6.39M Sell
508,790
-98,826
-16% -$910K ﹤0.01% 2585
2021
Q2
$4.93M Buy
607,616
+566,354
+1,373% +$4.91M ﹤0.01% 2774
2021
Q1
$382K Sell
41,262
-156,252
-79% -$1.58M ﹤0.01% 5042
2020
Q4
$1.91M Sell
197,514
-189,670
-49% -$1.87M ﹤0.01% 3273
2020
Q3
$4.8K Buy
387,184
+188,225
+95% +$2.5M 0.01% 1883
2020
Q2
$2.59M Buy
198,959
+78,324
+65% +$985K ﹤0.01% 2337
2020
Q1
$1.22M Sell
120,635
-88,046
-42% -$1.15M ﹤0.01% 2340
2019
Q4
$3.26M Buy
+208,681
New +$4.2M ﹤0.01% 2259
2019
Q2
Sell
-20,135
Closed -$436K 4192
2019
Q1
$436K Buy
+20,135
New +$420K ﹤0.01% 3356

Other funds holding GOSS

Millennium Management's GOSS Position: Q1 2026 in Review

Millennium Management reduced its Gossamer Bio (GOSS) stake by 95% in Q1 2026, selling an estimated $5.34M and leaving 187,418 shares worth $61.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5410.

Millennium Management first reported a position in GOSS in Q1 2019 and has held it in 27 quarters since. The position peaked at $15.9M in Q3 2022. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Millennium Management held 187,418 shares of Gossamer Bio worth $61.6K as of Q1 2026.
  • Millennium Management sold 3,396,870 Gossamer Bio shares in Q1 2026, an estimated $5.34M.
  • Gossamer Bio made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5410 holding.
  • Millennium Management first reported a position in Gossamer Bio in Q1 2019 and has held it in 27 quarters since.
  • Millennium Management's Gossamer Bio position peaked at $15.9M in Q3 2022.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.